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2018 Hospital Profile
Overview / Size Payer Mix
Hospital System Affiliation: Public Payer Mix:
Hospital System Surplus (Loss) in FY18: CY17 Commercial Statewide Relative Price:
Change in Ownership (FY14-18): Top 3 Commercial Payers:
Total Staffed Beds:
Change FY17-FY18:
Financial Emergency Department Visits in FY18:
Inpatient NPSR per CMAD: Change FY17-FY18:
Change FY17-FY18: Outpatient Visits in FY18:
`
For descriptions of the metrics, please see the technical appendix.  
What proportion of adult patient discharges from this hospital resulted in 
a readmission at any hospital within 30 days, and how does this 
compare to the state average?
How many central line-associated blood stream infections (CLABSI), 
catheter-associated urinary tract infections (CAUTI), and surgical site 
infections (SSI) after colon surgery did patients get at this hospital 
compared to what was expected based on the hospital's characteristics 
and case mix?
What were the most common inpatient cases (DRGs) treated at the 
hospital in FY18? What proportion of the region’s cases did this hospital 
treat for each service? 
Where did most of the hospital's inpatients reside? What proportion of 
each community's total discharges was attributed to this hospital?
 - - - Hospital  (1,304) = 0%  of total regional  discharges 
DANA-FARBER CANCER INSTITUTE
Boston, MA
Specialty Hospital
Metro Boston
Dana-Farber Cancer Institute is a nonprofit specialty hospital dedicated to pediatric and adult cancer treatment and research, located in the Metro Boston 
region. It is a teaching affiliate of Harvard Medical School. It is one of 49 Comprehensive Cancer Centers in the US, designated by the National Cancer 
Institute. Dana-Farber Cancer Institute provides the majority of its care in an outpatient setting and had 1,304 inpatient discharges compared to 286,608 
outpatient visits in FY18.  Dana-Farber has posted profits in each year of the five-year period, including a 6.3% total margin in FY18.
Quality
Early Elective Deliveries Rate: 
Change FY14-FY18 (percentage points):
$113,111,736
Total Revenue in FY18: $1,798,495,622
18.8%Change FY17-FY18:
Outpatient Revenue in FY18:
Not Available
Not AvailableReadmission Rate in FY18:
Blue Cross Blue Shield of Massachusetts
Harvard Pilgrim Health Care
Tufts Associated HMO, Inc.
Not Applicable
30, among the smallest acute hospitals
95.1%
50.5% Non-HPP Hospital
25.0%
Utilization
Inpatient Discharges in FY18:
Dana-Farber Cancer Institute and Subsid.
0
1.34
1,304
 $11,394
$106,732,714
4%:96%
$993,959,059
Inpatient:Outpatient Revenue in FY18:
Total Surplus (Loss) in FY18:
Change FY17-FY18:
% Occupancy:
Special Public Funding: Not Applicable
Not Applicable
Case Mix Index: 3.28 > statewide (1.14)
Trauma Center Designation:
0.0%
286,6080.5%
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This measure is not applicable to the patient 
population treated at this specialty hospital.
This graph has been suppressed, as no community accounted 
for more than 1% of the hospital's total discharges.
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Data is not available for these measures.
This graph has been suppressed, as the hospital provides the vast 
majority of its services on an outpatient basis.  In FY18, this hospital 
reported 160,655 infusion treatments and over 286,500 outpatient visits.
A57
Key:
Hospital
Cohort: Specialty Hospital Peer Cohort
For descriptions of the metrics, please see the technical appendix.
* High Public Payer Hospitals (HPP) receive a minimum of 63% of gross patient service revenue from public payers.
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How has the volume of the hospital's inpatient discharges changed 
compared to FY14, and how does this compare to the hospital's peer 
cohort median? (FY14=100)
How has the volume of the hospital's outpatient visits changed 
compared to FY14, and how does this compare to the hospital's peer 
cohort median? (FY14=100)
What was the hospital's net inpatient service revenue per case mix 
adjusted discharge between FY14 and FY18, and how does this 
compare to the hospital's peer cohort median?
How has the hospital's total outpatient revenue changed compared to 
FY14, and how does this compare to the hospital's peer cohort median? 
(FY14=100)
How have the hospital's total revenue and costs changed between FY14 
and FY18?
Total Profit (Loss) 34.6$     4.7$       43.3$     29.9$     
1,541$   
Total Revenue 1,098$   1,171$   1,382$   1,571$   
Total Costs 1,064$   1,166$   1,338$   
1,798$   
1,685$   
113.1$   
141$      
 Operating Revenue
Non-Operating 
Revenue
79$        53$        88$        165$      
What were the hospital's total margin and operating margins between 
FY14 and FY18, and how do these compare to the hospital's peer 
cohort medians?
Revenue, Cost, & Profit/Loss (in millions)
FY 2014 2015 2016 2017
1,019$   1,117$   1,293$   1,429$   1,634$   
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